2018 Global Cancer Targeted Therapy Industry Report - History, Present and Future

November 2018 | 147 pages | ID: 2EBB5ED8B59PEN
Prof Research

Abstracts

The global market size of Cancer Targeted Therapy is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by the end of 2023 with a CAGR of XX% from 2018 to 2023.

There are 3 key segments covered in this report: geography segment, end use/application segment and competitor segment.

For geography segment, regional supply, application-wise and type-wise demand, major players, price is presented from 2013 to 2023. This report coverss following regions:

• North America
• South America
• Asia & Pacific
• Europe
• MEA (Middle East and Africa)

The key countries in each region are taken into consideration as well, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For end use/application segment, this report focuses on the status and outlook for key applications. End users also can be listed.

For competitor segment, the report includes global key players of Cancer Targeted Therapy as well as some small players. The compnaies include:

Admera Health, Agena Biosciences, Agendia, AstraZeneca, Becton Dickinson, Atossa Genetics, Cancer Genetics, Celera Corporation et al.

The information for each competitor includes:

• Company Profile
• Main Business Information
• SWOT Analysis
• Sales, Revenue, Price and Gross Margin
• Market Share

We also can offer customized report to fulfill special requirements of our clients.

Contents

CHAPTER 1 EXECUTIVE SUMMARY

CHAPTER 2 ABBREVIATION AND ACRONYMS

CHAPTER 3 PREFACE

3.1 Research Scope
3.2 Research Methodology
  3.2.1 Data Collection
  3.2.2 Data Analysis
  3.2.3 Data Validation
3.3 Research Sources
  3.3.1 Primary Sources
  3.3.2 Secondary Sources
  3.3.3 Assumptions

CHAPTER 4 MARKET LANDSCAPE

4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users

CHAPTER 5 MARKET TREND ANALYSIS

5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats

CHAPTER 6 INDUSTRY CHAIN ANALYSIS

6.1 Upstream/Suppliers Analysis
6.2 Cancer Targeted Therapy Analysis
  6.2.1 Technology Analysis
  6.2.2 Cost Analysis
  6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users

CHAPTER 7 LATEST MARKET DYNAMICS

7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics

CHAPTER 8 TRADING ANALYSIS

8.1 Export of Cancer Targeted Therapy by Region
8.2 Import of Cancer Targeted Therapy by Region
8.3 Balance of Trade

CHAPTER 9 HISTORICAL AND CURRENT CANCER TARGETED THERAPY MARKET IN NORTH AMERICA (2013-2018)

9.1 Cancer Targeted Therapy Supply
9.2 Cancer Targeted Therapy Demand by End Use
9.3 Competition by Players/Suppliers
9.4 Type Segmentation and Price
9.5 Key Countries Analysis

CHAPTER 10 HISTORICAL AND CURRENT CANCER TARGETED THERAPY MARKET IN SOUTH AMERICA (2013-2018)

10.1 Cancer Targeted Therapy Supply
10.2 Cancer Targeted Therapy Demand by End Use
10.3 Competition by Players/Suppliers
10.4 Type Segmentation and Price
10.5 Key Countries Analysis

CHAPTER 11 HISTORICAL AND CURRENT CANCER TARGETED THERAPY MARKET IN ASIA & PACIFIC (2013-2018)

11.1 Cancer Targeted Therapy Supply
11.2 Cancer Targeted Therapy Demand by End Use
11.3 Competition by Players/Suppliers
11.4 Type Segmentation and Price
11.5 Key Countries Analysis

CHAPTER 12 HISTORICAL AND CURRENT CANCER TARGETED THERAPY MARKET IN EUROPE (2013-2018)

12.1 Cancer Targeted Therapy Supply
12.2 Cancer Targeted Therapy Demand by End Use
12.3 Competition by Players/Suppliers
12.4 Type Segmentation and Price
12.5 Key Countries Analysis

CHAPTER 13 HISTORICAL AND CURRENT CANCER TARGETED THERAPY MARKET IN MEA (2013-2018)

13.1 Cancer Targeted Therapy Supply
13.2 Cancer Targeted Therapy Demand by End Use
13.3 Competition by Players/Suppliers
13.4 Type Segmentation and Price
13.5 Key Countries Analysis

CHAPTER 14 SUMMARY FOR GLOBAL CANCER TARGETED THERAPY MARKET (2013-2018)

14.1 Cancer Targeted Therapy Supply
14.2 Cancer Targeted Therapy Demand by End Use
14.3 Competition by Players/Suppliers
14.4 Type Segmentation and Price

CHAPTER 15 GLOBAL CANCER TARGETED THERAPY MARKET FORECAST (2019-2023)

15.1 Cancer Targeted Therapy Supply Forecast
15.2 Cancer Targeted Therapy Demand Forecast
15.3 Competition by Players/Suppliers
15.4 Type Segmentation and Price Forecast

CHAPTER 16 COMPANY PROFILE(ADMERA HEALTH, AGENA BIOSCIENCES, AGENDIA, ASTRAZENECA, BECTON DICKINSON, ATOSSA GENETICS, CANCER GENETICS, CELERA CORPORATION ET AL.)

16.1 Company A
  16.1.1 Company Profile
  16.1.2 Main Business and Cancer Targeted Therapy Information
  16.1.3 SWOT Analysis of Company A
  16.1.4 Company A Cancer Targeted Therapy Sales, Revenue, Price and Gross Margin (2013-2018)
16.2 Company B
  16.2.1 Company Profile
  16.2.2 Main Business and Cancer Targeted Therapy Information
  16.2.3 SWOT Analysis of Company B
  16.2.4 Company B Cancer Targeted Therapy Sales, Revenue, Price and Gross Margin (2013-2018)
16.3 Company C
  16.3.1 Company Profile
  16.3.2 Main Business and Cancer Targeted Therapy Information
  16.3.3 SWOT Analysis of Company C
  16.3.4 Company C Cancer Targeted Therapy Sales, Revenue, Price and Gross Margin (2013-2018)
16.4 Company D
  16.4.1 Company Profile
  16.4.2 Main Business and Cancer Targeted Therapy Information
  16.4.3 SWOT Analysis of Company D
  16.4.4 Company D Cancer Targeted Therapy Sales, Revenue, Price and Gross Margin (2013-2018)
16.5 Company E
  16.5.1 Company Profile
  16.5.2 Main Business and Cancer Targeted Therapy Information
  16.5.3 SWOT Analysis of Company E
  16.5.4 Company E Cancer Targeted Therapy Sales, Revenue, Price and Gross Margin (2013-2018)
16.6 Company F
  16.6.1 Company Profile
  16.6.2 Main Business and Cancer Targeted Therapy Information
  16.6.3 SWOT Analysis of Company F
  16.6.4 Company F Cancer Targeted Therapy Sales, Revenue, Price and Gross Margin (2013-2018)
16.7 Company G
  16.7.1 Company Profile
  16.7.2 Main Business and Cancer Targeted Therapy Information
  16.7.3 SWOT Analysis of Company G
  16.7.4 Company G Cancer Targeted Therapy Sales, Revenue, Price and Gross Margin (2013-2018)

Tables & Figures

TABLES AND FIGURES

Table Abbreviation and Acronyms List
Table Research Scope of Cancer Targeted Therapy Report
Table Primary Sources of Cancer Targeted Therapy Report
Table Secondary Sources of Cancer Targeted Therapy Report
Table Major Assumptions of Cancer Targeted Therapy Report
Figure Cancer Targeted Therapy Picture
Table Cancer Targeted Therapy Classification
Table Cancer Targeted Therapy Applications List
Table Drivers of Cancer Targeted Therapy Market
Table Restraints of Cancer Targeted Therapy Market
Table Opportunities of Cancer Targeted Therapy Market
Table Threats of Cancer Targeted Therapy Market
Table Key Raw Material of Cancer Targeted Therapy and Its Suppliers
Table Key Technologies of Cancer Targeted Therapy
Table Cost Structure of Cancer Targeted Therapy
Table Market Channel of Cancer Targeted Therapy
Table Cancer Targeted Therapy Application and Key End Users List
Table Latest News of Cancer Targeted Therapy Industry
Table Recently Merger and Acquisition List of Cancer Targeted Therapy Industry
Table Recently Planned/Future Project List of Cancer Targeted Therapy Industry
Table Policy Dynamics Update of Cancer Targeted Therapy Industry
Table 2013-2023 Export of Cancer Targeted Therapy by Region
Table 2013-2023 Import of Cancer Targeted Therapy by Region
Table 2013-2023 Balance of Trade of Cancer Targeted Therapy
Figure 2013 2018 and 2023 Global Trade Map of Cancer Targeted Therapy
Table 2013-2018 North America Supply of Cancer Targeted Therapy
Figure 2013-2018 North America Cancer Targeted Therapy Supply and GAGR
Table 2013-2018 North America Cancer Targeted Therapy Downstream Demand List
Figure 2013-2018 North America Cancer Targeted Therapy Downstream Demand and CAGR
Figure 2013 Major Players Market Share in North America
Figure 2018 Major Players Market Share in North America
Table 2013-2018 North America Cancer Targeted Therapy Demand by Type
Figure 2013-2018 North America Cancer Targeted Therapy Price
Table 2013-2018 Key Countries Supply of Cancer Targeted Therapy in North America
Table 2013-2018 Key Countries Market Share of Supply in North America
Table 2013-2018 Key Countries Demand of Cancer Targeted Therapy in North America
Table 2013-2018 Key Countries Market Share of Demand in North America
Table 2013-2018 South America Supply of Cancer Targeted Therapy
Figure 2013-2018 South America Cancer Targeted Therapy Supply and GAGR
Table 2013-2018 South America Cancer Targeted Therapy Downstream Demand List
Figure 2013-2018 South America Cancer Targeted Therapy Downstream Demand and CAGR
Figure 2013 Major Players Market Share in South America
Figure 2018 Major Players Market Share in South America
Table 2013-2018 South America Cancer Targeted Therapy Demand by Type
Figure 2013-2018 South America Cancer Targeted Therapy Price
Table 2013-2018 Key Countries Supply of Cancer Targeted Therapy in South America
Table 2013-2018 Key Countries Market Share of Supply in South America
Table 2013-2018 Key Countries Demand of Cancer Targeted Therapy in South America
Table 2013-2018 Key Countries Market Share of Demand in South America
Table 2013-2018 Asia & Pacific Supply of Cancer Targeted Therapy
Figure 2013-2018 Asia & Pacific Cancer Targeted Therapy Supply and GAGR
Table 2013-2018 Asia & Pacific Cancer Targeted Therapy Downstream Demand List
Figure 2013-2018 Asia & Pacific Cancer Targeted Therapy Downstream Demand and CAGR
Figure 2013 Major Players Market Share in Asia & Pacific
Figure 2018 Major Players Market Share in Asia & Pacific
Table 2013-2018 Asia & Pacific Cancer Targeted Therapy Demand by Type
Figure 2013-2018 Asia & Pacific Cancer Targeted Therapy Price
Table 2013-2018 Key Countries Supply of Cancer Targeted Therapy in Asia & Pacific
Table 2013-2018 Key Countries Market Share of Supply in Asia & Pacific
Table 2013-2018 Key Countries Demand of Cancer Targeted Therapy in Asia & Pacific
Table 2013-2018 Key Countries Market Share of Demand in Asia & Pacific
Table 2013-2018 Europe Supply of Cancer Targeted Therapy
Figure 2013-2018 Europe Cancer Targeted Therapy Supply and GAGR
Table 2013-2018 Europe Cancer Targeted Therapy Downstream Demand List
Figure 2013-2018 Europe Cancer Targeted Therapy Downstream Demand and CAGR
Figure 2013 Major Players Market Share in Europe
Figure 2018 Major Players Market Share in Europe
Table 2013-2018 Europe Cancer Targeted Therapy Demand by Type
Figure 2013-2018 Europe Cancer Targeted Therapy Price
Table 2013-2018 Key Countries Supply of Cancer Targeted Therapy in Europe
Table 2013-2018 Key Countries Market Share of Supply in Europe
Table 2013-2018 Key Countries Demand of Cancer Targeted Therapy in Europe
Table 2013-2018 Key Countries Market Share of Demand in Europe
Table 2013-2018 MEA Supply of Cancer Targeted Therapy
Figure 2013-2018 MEA Cancer Targeted Therapy Supply and GAGR
Table 2013-2018 MEA Cancer Targeted Therapy Downstream Demand List
Figure 2013-2018 MEA Cancer Targeted Therapy Downstream Demand and CAGR
Figure 2013 Major Players Market Share in MEA
Figure 2018 Major Players Market Share in MEA
Table 2013-2018 MEA Cancer Targeted Therapy Demand by Type
Figure 2013-2018 MEA Cancer Targeted Therapy Price
Table 2013-2018 Key Countries Supply of Cancer Targeted Therapy in MEA
Table 2013-2018 Key Countries Market Share of Supply in MEA
Table 2013-2018 Key Countries Demand of Cancer Targeted Therapy in MEA
Table 2013-2018 Key Countries Market Share of Demand in MEA
Table 2013-2018 Global Supply of Cancer Targeted Therapy by Region
Figure 2013-2018 Global Supply and CAGR of Cancer Targeted Therapy by Region
Table 2013-2018 Global Cancer Targeted Therapy Downstream Demand List by Region
Figure 2013-2018 Global Cancer Targeted Therapy Downstream Demand and CAGR by Region
Figure 2013 Global Major Players Market Share
Figure 2018 Global Major Players Market Share
Table 2013-2018 Global Cancer Targeted Therapy Type-wise Demand by Region
Figure 2013-2018 Global Cancer Targeted Therapy Price
Table Main Business and Cancer Targeted Therapy Information of Company A
Table SWOT Analysis of Company A
Table 2013-2018 Company A Cancer Targeted Therapy Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company A Cancer Targeted Therapy Sales Revenue and Growth Rate
Figure 2013-2018 Company A Cancer Targeted Therapy Market Share
Table Main Business and Cancer Targeted Therapy Information of Company B
Table SWOT Analysis of Company B
Table 2013-2018 Company B Cancer Targeted Therapy Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company B Cancer Targeted Therapy Sales Revenue and Growth Rate
Figure 2013-2018 Company B Cancer Targeted Therapy Market Share
Table Main Business and Cancer Targeted Therapy Information of Company C
Table SWOT Analysis of Company C
Table 2013-2018 Company C Cancer Targeted Therapy Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company C Cancer Targeted Therapy Sales Revenue and Growth Rate
Figure 2013-2018 Company C Cancer Targeted Therapy Market Share
Table Main Business and Cancer Targeted Therapy Information of Company D
Table SWOT Analysis of Company D
Table 2013-2018 Company D Cancer Targeted Therapy Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company D Cancer Targeted Therapy Sales Revenue and Growth Rate
Figure 2013-2018 Company D Cancer Targeted Therapy Market Share
Table Main Business and Cancer Targeted Therapy Information of Company E
Table SWOT Analysis of Company E
Table 2013-2018 Company E Cancer Targeted Therapy Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company E Cancer Targeted Therapy Sales Revenue and Growth Rate
Figure 2013-2018 Company E Cancer Targeted Therapy Market Share
Table Main Business and Cancer Targeted Therapy Information of Company F
Table SWOT Analysis of Company F
Table 2013-2018 Company F Cancer Targeted Therapy Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company F Cancer Targeted Therapy Sales Revenue and Growth Rate
Figure 2013-2018 Company F Cancer Targeted Therapy Market Share
Table Main Business and Cancer Targeted Therapy Information of Company G
Table SWOT Analysis of Company G
Table 2013-2018 Company G Cancer Targeted Therapy Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company G Cancer Targeted Therapy Sales Revenue and Growth Rate
Figure 2013-2018 Company G Cancer Targeted Therapy Market Share